Health Catalyst Capital
Health Catalyst Capital is a New York-based private equity firm founded in 2015 that invests in U.S. lower-middle-market healthcare IT and tech-enabled services companies, managing capital from healthcare organizations, institutional investors, and family offices.
- Company typePrivate
- Founded2015
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Health Catalyst Capital does
Health Catalyst Capital (HCC) is a New York-based private equity firm founded in 2015 that invests in high-growth U.S. healthcare information technology and tech-enabled services businesses in the lower middle market. The firm is structured as Health Catalyst Capital Management LLC, governed by New York law, with a team of approximately eight named investment professionals led by Founder and Managing Partner Charles Boorady, and a stated network of relationships with over 250 major healthcare and technology enterprises used for deal sourcing and portfolio acceleration.
HCC's portfolio comprises 17 active investments spanning virtual care platforms (Cylinder, Pager Health), prescription digital therapeutics (Click Therapeutics), data analytics and AI enablement (Clearsense, Insightin, Datavant), diabetes management (Glooko), behavioral health analytics (Holmusk), provider network management (Quest Analytics), and population health engagement (HealthMine, ReferWell). Six of these portfolio companies were named to TIME's list of the World's Top HealthTech Companies of 2025, demonstrating portfolio quality. The firm explicitly positions itself as a hands-on investor that facilitates customer introductions, appoints value-add board members, and supports portfolio companies in integrating AI into their operations.
The firm generates revenue through traditional private equity fund management structures, including management fees on committed capital and carried interest on investment returns. Its limited partner base consists of large healthcare organizations, institutional investors, family offices, healthcare entrepreneurs, and senior executives. HCC does not develop proprietary technology products and its go-to-market is relationship-driven rather than channel-based, relying on its partner network and thought-leadership content (including articles on AI in healthcare and digital health employer trends) to source deals and attract LP capital.
Health Catalyst Capital firmographics
Firmographics- Name
- Health Catalyst Capital
- Legal name
- Health Catalyst Capital Management LLC
- Website
- https://healthcatalystcapital.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Health Catalyst Capital is a New York-based private equity firm founded in 2015 that invests in U.S. lower-middle-market healthcare IT and tech-enabled services companies, managing capital from healthcare organizations, institutional investors, and family offices.
- Ownership category
- akta.pro rank
Health Catalyst Capital industry classification
Industry- Product category
- Private Equity / Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Venture Capital (CVC) (FSANAAAF)
- akta.pro secondary industry
- Corporate LP Programs (Corporate as LP in VC/PE funds) (FSANAHAH)
Keywords
Where Health Catalyst Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Health Catalyst Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Fund Management: HCC generates revenue through traditional private equity fund management structures, including management fees and carried interest on investment returns. The firm invests capital from limited partners including large healthcare organizations, institutional investors, family offices, healthcare entrepreneurs and senior executives.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Health Catalyst Capital product offering
Product offeringCore offering
Health Catalyst Capital (HCC) is a New York-based private equity firm that raises capital from institutional investors, family offices, healthcare organizations, healthcare entrepreneurs, and senior executives, then deploys that capital as growth equity investments in U.S.-based, lower middle-market healthcare information technology and tech-enabled services companies. The firm provides portfolio companies with growth capital, operational expertise, AI integration support, board-level guidance, and facilitated introductions to customers and commercial partners.
Product overview
Health Catalyst Capital (HCC) is a New York-based private equity firm, not a product company. HCC does not offer its own products or services; instead, it invests in a portfolio of privately held healthcare technology and services companies. The portfolio includes virtual care platforms (Cylinder, Pager Health), data analytics/AI companies (Clearsense, Insightin), prescription digital therapeutics (Click Therapeutics), and various other healthcare IT businesses focused on care quality, access, and affordability.
Differentiator
Problem solved
Functional benefit
Products and services
- HCC Investment Portfolio Growth equity investments in privately held U.S. healthcare technology and tech-enabled services businesses in the lower middle market, including virtual care platforms, data analytics/AI companies, prescription digital therapeutics, behavioral health EMRs, and provider network management platforms. The fund is offered to limited partners including large healthcare organizations, institutional investors, family offices, healthcare entrepreneurs, and senior executives.
Companies that use Health Catalyst Capital
Customer profileSegments2 records
Ideal customer profiles2 records
Health Catalyst Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Health Catalyst Capital partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
Health Catalyst Capital competitors and assessment
Company assessmentBroad incumbents
- New Mountain Capital: Large healthcare-services and healthcare-IT focused PE firm with dedicated healthcare vertical. Comparable sector specialization but materially larger AUM and broader deal-size range than HCC.
- Bessemer Venture Partners (Healthcare): Long-standing venture and growth firm with a dedicated healthcare practice investing in healthcare IT, services, and biotech. Comparable sector coverage but operates across venture and growth stages with much larger flagship funds.
- General Atlantic: Global growth-equity firm with a significant healthcare technology practice. Comparable in deploying growth capital into healthcare IT and tech-enabled services, but at much larger check sizes and broader geographic footprint.
- Welsh, Carson, Anderson & Stowe: Established healthcare-focused PE firm with deep sector relationships and a multi-billion-dollar fund franchise. Highly comparable to HCC in vertical specialization (healthcare) but operates at materially larger fund sizes and broader team, making it a benchmark for HCC's growth trajectory.
Direct peers
- Optum Ventures: CVC arm of Optum/UnitedHealth Group investing in healthcare data, analytics, and care-delivery technology. Directly competes for healthcare IT deals in similar stage ranges and benefits from corporate strategic LP-style value-add analogous to HCC's healthcare-organization LPs.
- Oak HC/FT: Specialist growth equity and early-stage investor focused exclusively on healthcare IT and fintech. Directly comparable to HCC in target market (healthcare technology companies), investor approach, and lower-middle-market focus, with a similarly hands-on operating model.
- TT Capital Partners: Niche PE firm focused on healthcare technology and tech-enabled services, with comparable target company stage and value-add operating approach. Direct competitor for healthcare IT growth-equity deals in similar check-size range.
- Echo Health Ventures: Strategic healthcare CVC formed by Cambia Health Solutions and Mosaic Health Solutions investing across healthcare IT and tech-enabled services. Direct competitor for healthcare IT deals with corporate strategic LP value-add analogous to HCC's healthcare-organization LP base.
- Norwest Venture Partners (Healthcare): Growth-equity firm with a longstanding healthcare investing practice covering healthcare IT, services, and devices. Comparable in growth-stage healthcare IT focus and operating-value-add orientation; slightly broader stage range than HCC.
Emerging players
- Andreessen Horowitz (a16z) Bio + Health: Major venture firm with dedicated bio/health fund investing across healthcare IT, digital health, and biotech. Overlaps HCC's healthcare IT thesis at earlier-stage check sizes and provides competitive fundraising for healthcare-founder mindshare.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks2 records
Key highlights7 records
Customer concentration
Health Catalyst Capital social profiles
Digital presenceHealth Catalyst Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Health Catalyst Capital leadership team
Management profileNumber of profiles
Profiles9 records
Health Catalyst Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Health Catalyst Capital M&A and investment
M&A and investmentM&A
Investments33 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Health Catalyst Capital
What does Health Catalyst Capital do?
Health Catalyst Capital (HCC) is a New York-based private equity firm that raises capital from institutional investors, family offices, healthcare organizations, healthcare entrepreneurs, and senior executives, then deploys that capital as growth equity investments in U.S.-based, lower middle-market healthcare information technology and tech-enabled services companies. The firm provides portfolio companies with growth capital, operational expertise, AI integration support, board-level guidance, and facilitated introductions to customers and commercial partners.
Is Health Catalyst Capital a public or private company?
Health Catalyst Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Health Catalyst Capital founded?
Health Catalyst Capital was founded in 2015. It employs 11 to 50 people.
Where is Health Catalyst Capital based?
Health Catalyst Capital is headquartered in New York, United States, in the North America region.
How does Health Catalyst Capital make money?
One revenue line is on record: fund Management.
Who are Health Catalyst Capital's main competitors?
Broad incumbents on record are New Mountain Capital, Bessemer Venture Partners (Healthcare), General Atlantic and Welsh, Carson, Anderson & Stowe. Direct peers are Optum Ventures, Oak HC/FT, TT Capital Partners, Echo Health Ventures and Norwest Venture Partners (Healthcare). Andreessen Horowitz (a16z) Bio + Health is listed as an emerging player.
Does Health Catalyst Capital have an API?
No public API is recorded for Health Catalyst Capital.
What industry is Health Catalyst Capital in?
Health Catalyst Capital's product category is Private Equity / Venture Capital. Its primary akta.pro industry code is FSANAAAF, Corporate Venture Capital (CVC), with a secondary code of FSANAHAH, Corporate LP Programs (Corporate as LP in VC/PE funds). Its NAICS code is 523940 and its SIC code is 6282.